{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T03:39:51Z","timestamp":1785555591058,"version":"3.56.0"},"reference-count":14,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2022,1,17]],"date-time":"2022-01-17T00:00:00Z","timestamp":1642377600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,5,30]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:p>Intraperitoneal (IP) administration of antibiotics is a preferred treatment of peritoneal dialysis (PD)-related peritonitis. Given the treatment duration of up to 2\u20133 weeks, it is important that robust data on antibiotic stability and compatibility are available to achieve notable treatment success. This article provides a comprehensive review of recent stability and compatibility studies pertaining to a wide range of antibiotics admixed in various PD solutions.<\/jats:p>","DOI":"10.1093\/ckj\/sfac012","type":"journal-article","created":{"date-parts":[[2022,1,13]],"date-time":"2022-01-13T20:13:24Z","timestamp":1642104804000},"page":"1071-1078","source":"Crossref","is-referenced-by-count":20,"title":["Stability and compatibility of antibiotics in peritoneal dialysis solutions"],"prefix":"10.1093","volume":"15","author":[{"given":"Simon Wai Yin","family":"So","sequence":"first","affiliation":[{"name":"Pharmacy Department, Alice Ho Miu Ling Nethersole Hospital , Tai Po , Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Chen","sequence":"additional","affiliation":[{"name":"Pharmacy Department, Alice Ho Miu Ling Nethersole Hospital , Tai Po , Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex Yuk Hei","family":"Woo","sequence":"additional","affiliation":[{"name":"Pharmacy Department, Alice Ho Miu Ling Nethersole Hospital , Tai Po , Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek Man Him","family":"Ng","sequence":"additional","affiliation":[{"name":"Pharmacy Department, Prince of Wales Hospital , Shatin , Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer Ka Wah","family":"Wong","sequence":"additional","affiliation":[{"name":"Pharmacy Department, Prince of Wales Hospital , Shatin , Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai Ming","family":"Chow","sequence":"additional","affiliation":[{"name":"Department of Medicine and Therapeutics, Carol and Richard Yu Peritoneal Dialysis Research Centre, Prince of Wales Hospital, Chinese University of Hong Kong , Shatin , Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi","family":"Runnegar","sequence":"additional","affiliation":[{"name":"University of Queensland at Princess Alexandra Hospital , Brisbane, QLD , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W","family":"Johnson","sequence":"additional","affiliation":[{"name":"University of Queensland at Princess Alexandra Hospital , Brisbane, QLD , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9879-8388","authenticated-orcid":false,"given":"Philip Kam-Tao","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Medicine and Therapeutics, Carol and Richard Yu Peritoneal Dialysis Research Centre, Prince of Wales Hospital, Chinese University of Hong Kong , Shatin , Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,1,17]]},"reference":[{"key":"2022053122142233100_bib1","doi-asserted-by":"crossref","first-page":"481","DOI":"10.3747\/pdi.2016.00078","article-title":"ISPD peritonitis recommendations: 2016 update on prevention and treatment","volume":"36","author":"Li","year":"2016","journal-title":"Perit Dial Int"},{"key":"2022053122142233100_bib2","doi-asserted-by":"crossref","first-page":"421","DOI":"10.3747\/pdi.2015.00062","article-title":"Stability of antibiotics for intraperitoneal administration in Extraneal 7.5% Icodextrin Peritoneal Dialysis Bags (STAB Study)","volume":"36","author":"Ranganathan","year":"2016","journal-title":"Perit Dial Int"},{"key":"2022053122142233100_bib3","doi-asserted-by":"crossref","first-page":"676","DOI":"10.3747\/pdi.2015.00018","article-title":"Stability and compatibility of antibiotics in peritoneal dialysis solutions applied to automated peritoneal dialysis in the pediatric population","volume":"36","author":"Deslandes","year":"2016","journal-title":"Perit Dial Int"},{"key":"2022053122142233100_bib4","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/089686080902900101","article-title":"Intraperitoneal administration of drugs in peritoneal dialysis patients: a review of compatibility and guidance for clinical use","volume":"29","author":"de Vin","year":"2009","journal-title":"Perit Dial Int"},{"key":"2022053122142233100_bib5","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1177\/0896860819887636","article-title":"Pyridine levels in ceftazidime \u2013 peritoneal dialysis admixtures stored at body temperature","volume":"40","author":"Nguyen","year":"2020","journal-title":"Perit Dial Int"},{"key":"2022053122142233100_bib6","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1016\/j.clinthera.2019.08.021","article-title":"High pyridine generation in ceftazidime-icodextrin admixtures used to treat peritoneal dialysis-associated peritonitis","volume":"41","author":"Kaur","year":"2019","journal-title":"Clin Ther"},{"key":"2022053122142233100_bib7","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3747\/pdi.2017.00115","article-title":"Stability of ceftazidime and heparin in four different types of peritoneal dialysis solutions","volume":"38","author":"Kandel","year":"2018","journal-title":"Perit Dial Int"},{"key":"2022053122142233100_bib8","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1128\/AAC.02637-13","article-title":"How to minimize toxic exposure to pyridine during continuous infusion of ceftazidime in patients with cystic fibrosis?","volume":"58","author":"Bourget","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"2022053122142233100_bib9","author":"European Medicines Agency","year":"2010","journal-title":"ICH topic Q3C (R4). Impurities: guideline for residual solvent"},{"key":"2022053122142233100_bib10","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3747\/pdi.2015.00169","article-title":"Stability of cefepime in pH-neutral peritoneal dialysis solutions packaged in dual-compartment bags","volume":"36","author":"Yousaf","year":"2016","journal-title":"Perit Dial Int"},{"key":"2022053122142233100_bib11","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2146\/ajhp130717","article-title":"Stability of ampicillin and amoxicillin in peritoneal dialysis solutions","volume":"72","author":"Patel","year":"2015","journal-title":"Am J Health Syst Pharm"},{"key":"2022053122142233100_bib12","doi-asserted-by":"crossref","first-page":"430","DOI":"10.3747\/pdi.2017.00274","article-title":"Stability of meropenem and piperacillin\/tazobactam with heparin in various peritoneal dialysis solutions","volume":"38","author":"Mendes","year":"2018","journal-title":"Perit Dial Int"},{"key":"2022053122142233100_bib13","doi-asserted-by":"crossref","first-page":"6512","DOI":"10.1038\/s41598-019-42854-y","article-title":"Compatibility of ciprofloxacin with commercial peritoneal dialysis solutions","volume":"9","author":"Kussmann","year":"2019","journal-title":"Sci Rep"},{"key":"2022053122142233100_bib14","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1345\/aph.1G321","article-title":"Stability of vancomycin in icodextrin peritoneal dialysis solution","volume":"40","author":"Nornoo","year":"2006","journal-title":"Ann Pharmacother"}],"container-title":["Clinical Kidney Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ckj\/advance-article-pdf\/doi\/10.1093\/ckj\/sfac012\/42927095\/sfac012.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/15\/6\/1071\/43890958\/sfac012.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/15\/6\/1071\/43890958\/sfac012.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T22:14:57Z","timestamp":1654035297000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ckj\/article\/15\/6\/1071\/6509498"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,17]]},"references-count":14,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,1,17]]},"published-print":{"date-parts":[[2022,5,30]]}},"URL":"https:\/\/doi.org\/10.1093\/ckj\/sfac012","relation":{},"ISSN":["2048-8505","2048-8513"],"issn-type":[{"value":"2048-8505","type":"print"},{"value":"2048-8513","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,6]]},"published":{"date-parts":[[2022,1,17]]}}}